Our state-of-the-art imaging facilities span preclinical and clinical imaging, and include the Sydney Neuroimaging Analysis Centre.
The Brain and Mind Centre is home to the University of Sydney and Australian Nuclear Science and Technology Organisation (ANSTO) Node of the Australian National Imaging Facility. This shared facility provides researchers with access to state-of-the-art imaging capabilities for research. The preclinical imaging platform includes micro-PET, PET-CT, PET/SPECT/CT and 3T Magnetic Resonance Imaging (MRI) scanners as well as autoradiography, radiometabolite analysis and tissue counting facilities.
The facility will shortly be enhanced by the acquisition of a Positron Emission Tomography (PET) insert for the 3T MRI providing PET-MRI imaging capability for neuroscientists requiring simultaneous multimodal imaging. In collaboration with ANSTO, facility users can also access cyclotron-based radioisotopes, such as carbon and fluorine and radiochemistry expertise in both vessel and microfluidic systems, via the adjacent National Imaging Facility (NIF) cyclotron facility.
Our imaging researchers are focused on developing new brain cancer technologies for non-invasive imaging and imaging biomarker development. We collaborate with many researchers at the Brain and Mind Centre and overseas to develop new imaging methods and test new drugs and interventions for various brain disorders, including neurodegenerative diseases, mood disorders and cancer.
Our imaging scientists have an outstanding track record in preclinical imaging innovation. They have developed novel technologies for the advancement of neuroimaging research and for the understanding of disease processes.
I-MED is a leading provider of radiological services in Sydney, operating a network of radiology practices across the city, including an imaging research facility here at the Brain and Mind Centre. This facility houses a state-of-the-art 3 Tesla Magnetic Resonance Imaging (MRI) scanner capable of running structural, diffusion, functional and spectroscopic imaging for research as well as for patient care.
Through our collaboration with I-MED, researchers at the Brain and Mind Centre have developed a sophisticated multinuclear spectroscopy program that provides the ability to image a range of spectroscopic nuclei. The technique, known as magnetic resonance spectroscopy (MRS), is used to study the metabolic changes associated with diseases that affect the brain. It also provides additional information on top of the structural information that is obtained from MRI alone.
Our expertise in this area is enabling researchers to study the changes that occur in the brain as a result of a particular disease, which may ultimately be helpful in the clinical diagnosis and treatment of these diseases.
Also housed in the Brain and Mind Centre is the Sydney Neuroimaging Analysis Centre, a leading-edge facility that uniquely integrates in-house neuroimaging research with a dedicated, regulatory-compliant commercial image analysis facility for Phase 2, 3 and 4 clinical research trials.